Västra Hamnen Market Focus: Gabather: Phase II finally activated
2 juni, 08:00
2 juni, 08:00
Gabather's first report of 2026 came in close to our estimates, with an EBIT of KSEK -1 052 against our projected KSEK -1 136. The real news came in May, when the company announced that the long-awaited TOTEMS phase II trial had been activated; a double-blind, randomised study with both schizophrenia patients and healthy controls, with data read out continuously. CEO Michael-Robin Witt has expressed hopes of publishing an interim report this autumn. In April, Gabather also filed a patent for a new non-sedating sleep treatment and entered partnerships aimed at opening doors to licensing discussions. We make no changes to our financial model and keep our fair value of SEK 0.06 per share.
The full report is available here.
About Market Focus
The research report is prepared as part of Market Focus, Västra Hamnen Corporate Finance's commissioned research offering.
This is a press release from Västra Hamnen Corporate Finance AB.
Web: vhcorp.se
Twitter: @vhcorp_se (https://x.com/vhcorp_se)
2 juni, 08:00
Gabather's first report of 2026 came in close to our estimates, with an EBIT of KSEK -1 052 against our projected KSEK -1 136. The real news came in May, when the company announced that the long-awaited TOTEMS phase II trial had been activated; a double-blind, randomised study with both schizophrenia patients and healthy controls, with data read out continuously. CEO Michael-Robin Witt has expressed hopes of publishing an interim report this autumn. In April, Gabather also filed a patent for a new non-sedating sleep treatment and entered partnerships aimed at opening doors to licensing discussions. We make no changes to our financial model and keep our fair value of SEK 0.06 per share.
The full report is available here.
About Market Focus
The research report is prepared as part of Market Focus, Västra Hamnen Corporate Finance's commissioned research offering.
This is a press release from Västra Hamnen Corporate Finance AB.
Web: vhcorp.se
Twitter: @vhcorp_se (https://x.com/vhcorp_se)
Aktieanalys




30 juni, 07:20

Saab
Aktieanalys
Privatekonomi
H&M rapporterar
Aktieanalys
1 DAG %
Senast
OMX Stockholm 30
0,85%
(14:26)
Indutrade
Idag, 14:08
Indutrade: Dags för revansch?
Saab
Idag, 13:21
Finland köper Saabs luftvärnssystem
OMX Stockholm 30
1 DAG %
Senast
3 237,26